BMPs in bone regeneration: Less is more effective, a paradigm-shift

Cytokine and Growth Factor Reviews

Volumn 27, Issue , 2016, Pages 141-148

  Schmidt Bleek, Katharina ^a   Willie, Bettina M ^a,b   Schwabe, Philipp ^a   Seemann, Petra ^a   Duda, Georg N ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

BMP2; Bone healing; Bone morphogenetic protein; Growth factor; Regeneration

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BMP2 PROTEIN, HUMAN;

BONE REGENERATION; FEEDBACK SYSTEM; FRACTURE HEALING; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DOSE RESPONSE; DRUG EFFECTS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FRACTURE HEALING; HUMANS;

EID: 84957432280     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2015.11.006     Document Type: Short Survey

References (77)

1. Senn N. On the healing of aseptic bone cavities by implantation of antiseptic decalcified bone. Am. J. Med. Sci. 1889, 98:219-240.
2. Levander G. On the formation of new bone in bone transplantation. Acta Chir. Scand. 1934, 74:425-426.
3. Levander G. A study of bone regeneration. Surg. Gynecol. Obstet. 1938, 67:705-714.
4. Levander G. Tissue induction. Nature 1945, 155:148-149.
5. Lacroix P. Recent investigation on the growth of bone. Nature 1945, 156.
6. Urist M.R., Strates B.S. Bone morphogenetic protein. J. Dent. Res. 1971, 50:1392-1406.
7. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
8. Reddi A.H., Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc. Natl. Acad. Sci. U. S. A. 1972, 69:1601-1605.
9. Govender S., Csimma C., Genant H.K., Valentin-Opran A., Amit Y., Arbel R., Aro H., Atar D., Bishay M., Borner M.G., Chiron P., Choong P., Cinats J., Courtenay B., Feibel R., Geulette B., Gravel C., Haas N., Raschke M., Hammacher E., van der Velde D., Hardy P., Holt M., Josten C., Ketterl R.L., Lindeque B., Lob G., Mathevon H., McCoy G., Marsh D., Miller R., Munting E., Oevre S., Nordsletten L., Patel A., Pohl A., Rennie W., Reynders P., Rommens P.M., Rondia J., Rossouw W.C., Daneel P.J., Ruff S., Ruter A., Santavirta S., Schildhauer T.A., Gekle C., Schnettler R., Segal D., Seiler H., Snowdowne R.B., Stapert J., Taglang G., Verdonk R., Vogels L., Weckbach A., Wentzensen A., Wisniewski T., Group BMPEiSfTTS Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Joint Surg. Am. 2002, 84-A:2123-2134.
10. Jones A.L., Bucholz R.W., Bosse M.J., Mirza S.K., Lyon T.R., Webb L.X., Pollak A.N., Golden J.D., Valentin-Opran A., Group BMPEiSfTT-AS Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J. Bone Joint Surg. Am. 2006, 88:1431-1441.
11. Riedel G.E., Valentin-Opran A. Clinical evaluation of rhBMP-2/ACS in orthopedic trauma: a progress report. Orthopedics 1999, 22:663-665.
12. Swiontkowski M.F., Aro H.T., Donell S., Esterhai J.L., Goulet J., Jones A., Kregor P.J., Nordsletten L., Paiement G., Patel A. Recombinant human bone morphogenetic protein-2 in open tibial fractures: a subgroup analysis of data combined from two prospective randomized studies. J. Bone Joint Surg. Am. 2006, 88:1258-1265.
13. Wei S., Cai X., Huang J., Xu F., Liu X., Wang Q. Recombinant human BMP-2 for the treatment of open tibial fractures. Orthopedics 2012, 35:e847-e854.
14. Carragee E.J., Hurwitz E.L., Weiner B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011, 11:471-491.
15. Carragee E.J., Hurwitz E.L., Weiner B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011, 11(6):471-491.
16. Garrison K.R., Shemilt I., Donell S., Ryder J.J., Mugford M., Harvey I., Song F., Alt V. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst. Rev. 2010, CD006950.
17. Lad S.P., Bagley J.H., Karikari I.O., Babu R., Ugiliweneza B., Kong M., Isaacs R.E., Bagley C.A., Gottfried O.N., Patil C.G., Boakye M. Cancer after spinal fusion: the role of bone morphogenetic protein. Neurosurgery 2013, 73:440-449.
18. Gao H., Chakraborty G., Lee-Lim A.P., Mo Q., Decker M., Vonica A., Shen R., Brogi E., Brivanlou A.H., Giancotti F.G. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell 2012, 150:764-779.
19. Owens P., Pickup M.W., Novitskiy S.V., Chytil A., Gorska A.E., Aakre M.E., West J., Moses H.L. Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2814-2819.
20. Gitelis S., Wilkins R.M., Yasko A.W. BMP and Cancer: Is the Risk Real? 2008, AAOS Now.
21. Carragee E.J., Mitsunaga K.A., Hurwitz E.L., Scuderi G.J. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study. Spine J. 2011, 11:511-516.
22. Aro H.T., Govender S., Patel A.D., Hernigou P., Perera, de G., regorio A., Popescu G.I., Golden J.D., Christensen J., Valentin A. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J. Bone Joint Surg. Am. 2011, 93:801-808.
23. Axelrad T.W., Steen B., Lowenberg D.W., Creevy W.R., Einhorn T.A. Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients. J. Bone Joint Surg. Br. 2008, 90:1617-1622.
24. Urist M.R., Huo Y.K., Brownell A.G., Hohl W.M., Buyske J., Lietze A., Tempst P., Hunkapiller M., DeLange R.J. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:371-375.
25. Han D., Liu W., Ao Q., Wang G. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix. Med. Hypotheses 2008, 71:374-378.
26. Haidar Z.S., Hamdy R.C., Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol. Lett. 2009, 31:1817-1824.
27. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
28. Boyne P.J., Marx R.E., Nevins M., Triplett G., Lazaro E., Lilly L.C., Alder M., Nummikoski P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int. J. Periodontics Restor. Dent. 1997, 17:11-25.
29. Campana V., Milano G., Pagano E., Barba M., Cicione C., Salonna G., Lattanzi W., Logroscino G. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J. Mater. Sci. Mater. Med. 2014, 25:2445-2461.
30. Suh D.Y., Boden S.D., Louis-Ugbo J., Mayr M., Murakami H., Kim H.S., Minamide A., Hutton W.C. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine 2002, 27:353-360. (Phila, Pa 1976).
31. Wulsten D., Glatt V., Ellinghaus A., Schmidt-Bleek K., Petersen A., Schell H., Lienau J., Sebald W., Ploger F., Seemann P., Duda G.N. Time kinetics of bone defect healing in response to BMP-2 and GDF-5 characterised by in vivo biomechanics. Eur. Cell Mater. 2011, 21:177-192.
32. Mehta M., Schell H., Schwarz C., Peters A., Schmidt-Bleek K., Ellinghaus A., Bail H.J., Duda G.N., Lienau J. A 5 mm femoral defect in female but not in male rats leads to a reproducible atrophic non-union. Arch. Orthop. Trauma. Surg. 2011, 131:121-129.
33. Boerckel J.D., Kolambkar Y.M., Dupont K.M., Uhrig B.A., Phelps E.A., Stevens H.Y., Garcia A.J., Guldberg R.E. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 2011, 32:5241-5251.
34. Friedlaender G.E., Perry C.R., Cole J.D., Cook S.D., Cierny G., Muschler G.F., Zych G.A., Calhoun J.H., LaForte A.J., Yin S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. Am. 2001, 83-A(Suppl. 1):S151-S158.
35. Schwabe P., Greiner S., Ganzert R., Eberhart J., Dahn K., Stemberger A., Plank C., Schmidmaier G., Wildemann B. Effect of a novel nonviral gene delivery of BMP-2 on bone healing. Sci.World J. 2012, 2012. 560142.
36. Strobel C., Bormann N., Kadow-Romacker A., Schmidmaier G., Wildemann B. Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants. J. Control Release 2011, 156:37-45.
37. Schmidmaier G., Capanna R., Wildemann B., Beque T., Lowenberg D. Bone morphogenetic proteins in critical-size bone defects: what are the options?. Injury 2009, 40(Suppl. 3):S39-S43.
38. Wang Q., Huang C., Xue M., Zhang X. Expression of endogenous BMP-2 in periosteal progenitor cells is essential for bone healing. Bone 2011, 48:524-532.
39. Seemann P., Brehm A., Konig J., Reissner C., Stricker S., Kuss P., Haupt J., Renninger S., Nickel J., Sebald W., Groppe J.C., Ploger F., Pohl J., Schmidt-von Kegler M., Walther M., Gassner I., Rusu C., Janecke A.R., Dathe K., Mundlos S. Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN. PLoS Genet. 2009, 5:e1000747.
40. Grgurevic L., Macek B., Mercep M., Jelic M., Smoljanovic T., Erjavec I., Dumic-Cule I., Prgomet S., Durdevic D., Vnuk D., Lipar M., Stejskal M., Kufner V., Brkljacic J., Maticic D., Vukicevic S. Bone morphogenetic protein (BMP) 1-3 enhances bone repair. Biochem. Biophys. Res. Commun. 2011, 408:25-31.
41. Devlin R.D., Du Z., Pereira R.C., Kimble R.B., Economides A.N., Jorgetti V., Canalis E. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 2003, 144:1972-1978.
42. Rosen V. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev. 2009, 20:475-480.
43. McDonald M.M. Pre-clinical fracture repair investigations: meeting report from the 32nd annual meeting of the american society for bone and mineral research. BoneKEy 2011, 8(March):165-170.
44. Intini G., Cox K., Rosen V. Expression of BMP2 in skeletal progenitor cells is required for bone fracture repair. J. Bone Miner. Res. 2010, 25(S1):S1-S81.
45. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell Biochem. 2003, 88:873-884.
46. Ferguson M.W., O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R. Soc. London B. Biol. Sci. 2004, 359:839-850.
47. Sartori R., Sandri M. BMPs and the muscle-bone connection. Bone 2015.
48. Bier E., De Robertis E.M. Embryo development. BMP gradients: a paradigm for morphogen-mediated developmental patterning. Science 2015, 348:aaa5838.
49. Utturkar A., Paul B., Akkiraju H., Bonor J., Dhurjati P., Nohe A. Development of physiologically based pharmacokinetic model (PBPK) of BMP2 in mice. Biol. Syst. Open Access 2013, 2.
50. Gazzerro E., Canalis E. Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 2006, 7:51-65.
51. Groppe J., Greenwald J., Wiater E., Rodriguez-Leon J., Economides A.N., Kwiatkowski W., Affolter M., Vale W.W., Izpisua Belmonte J.C., Choe S. Structural basis of BMP signalling inhibition by the cystine knot protein noggin. Nature 2002, 420:636-642.
52. Krause C., Guzman A., Noggin Knaus P. Int. J. Biochem. Cell Biol. 2011, 43:478-481.
53. Tsiridis E., Upadhyay N., Giannoudis P. Molecular aspects of fracture healing: which are the important molecules?. Injury 2007, 38(Suppl. 1):S11-25.
54. Degenkolbe E., Schwarz C., Ott C.E., Konig J., Schmidt-Bleek K., Ellinghaus A., Schmidt T., Lienau J., Ploger F., Mundlos S., Duda G.N., Willie B.M., Seemann P. Improved bone defect healing by a superagonistic GDF5 variant derived from a patient with multiple synostoses syndrome. Bone 2015, 73:111-119.
55. Song K., Krause C., Shi S., Patterson M., Suto R., Grgurevic L., Vukicevic S., van Dinther M., Falb D., Ten Dijke P., Alaoui-Ismaili M.H. Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior agonist activity. J. Biol. Chem. 2010, 285:12169-12180.
56. Seemann P., Mundlos S., Reissner C., Duda G.N., Zimmer J. Bone Morphogenetic Protein 2 (bmp2) Variants with Reduced BMP Antagonist Sensitivity 2010, Berlin C-U, Germany.
57. Vukicevic S., Oppermann H., Verbanac D., Jankolija M., Popek I., Curak J., Brkljacic J., Pauk M., Erjavec I., Francetic I., Dumic-Cule I., Jelic M., Durdevic D., Vlahovic T., Novak R., Kufner V., Bordukalo Niksic T., Kozlovic M., Banic Tomisic Z., Bubic-Spoljar J., Bastalic I., Vikic-Topic S., Peric M., Pecina M., Grgurevic L. The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing. Int. Orthop. 2014, 38:635-647.
58. Wang Y., Hong S., Li M., Zhang J., Bi Y., He Y., Liu X., Nan G., Su Y., Zhu G., Li R., Zhang W., Wang J., Zhang H., Kong Y., Shui W., Wu N., He Y., Chen X., Luu H.H., Haydon R.C., Shi L.L., He T.C., Qin J. Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells. J. Orthop. Res. 2013, 31:1796-1803.
59. Albers C.E., Hofstetter W., Sebald H.J., Sebald W., Siebenrock K.A., Klenke F.M. L51P-A BMP2 variant with osteoinductive activity via inhibition of noggin. Bone 2012, 51:401-406.
60. Willie B.M., Blakytny R., Glockelmann M., Ignatius A., Claes L. Temporal variation in fixation stiffness affects healing by differential cartilage formation in a rat osteotomy model. Clin. Orthop. Relat. Res. 2011.
61. Rauch F., Lauzier D., Croteau S., Travers R., Glorieux F.H., Hamdy R. Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone 2000, 27:453-459.
62. Siddhivarn C., Banes A., Champagne C., Riche E.L., Weerapradist W., Offenbacher S. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line. J. Periodontal. Res. 2007, 42:383-392.
63. Sumanasinghe R.D., Bernacki S.H., Loboa E.G. Osteogenic differentiation of human mesenchymal stem cells in collagen matrices: effect of uniaxial cyclic tensile strain on bone morphogenetic protein (BMP-2) mRNA expression. Tissue Eng. 2006, 12:3459-3465.
64. Rui Y.F., Lui P.P., Ni M., Chan L.S., Lee Y.W., Chan K.M. Mechanical loading increased BMP-2 expression which promoted osteogenic differentiation of tendon-derived stem cells. J. Orthop. Res. 2011, 29:390-396.
65. Radomisli T.E., Moore D.C., Barrach H.J., Keeping H.S., Ehrlich M.G. Weight-bearing alters the expression of collagen types I and II, BMP 2/4 and osteocalcin in the early stages of distraction osteogenesis. J. Orthop. Res. 2001, 19:1049-1056.
66. Sato M., Ochi T., Nakase T., Hirota S., Kitamura Y., Nomura S., Yasui N. Mechanical tension-stress induces expression of bone morphogenetic protein (BMP)-2 and BMP-4, but not BMP-6, BMP-7, and GDF-5 mRNA, during distraction osteogenesis. J. Bone Miner. Res. 1999, 14:1084-1095.
67. Sato M., Yasui N., Nakase T., Kawahata H., Sugimoto M., Hirota S., Kitamura Y., Nomura S., Ochi T. Expression of bone matrix proteins mRNA during distraction osteogenesis. J Bone Miner. Res. 1998, 13:1221-1231.
68. Aspenberg P., Basic N., Tagil M., Vukicevic S. Reduced expression of BMP-3 due to mechanical loading: a link between mechanical stimuli and tissue differentiation. Acta Orthop. Scand. 2000, 71:558-562.
69. Alam N., St-Arnaud R., Lauzier D., Rosen V., Hamdy R.C. Are endogenous BMPs necessary for bone healing during distraction osteogenesis?. Clin. Orthop. Relat. Res. 2009, 467:3190-3198.
70. Campisi P., Hamdy R.C., Lauzier D., Amako M., Rauch F., Lessard M.L. Expression of bone morphogenetic proteins during mandibular distraction osteogenesis. Plast Reconstr. Surg. 2003, 111:201-208. discussion 209-10.
71. Boerckel J.D., Uhrig B.A., Willett N.J., Huebsch N., Guldberg R.E. Mechanical regulation of vascular growth and tissue regeneration in vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:E674-E680.
72. Boerckel J.D., Dupont K.M., Kolambkar Y.M., Lin A.S., Guldberg R.E. In vivo model for evaluating the effects of mechanical stimulation on tissue-engineered bone repair. J. Biomech. Eng. 2009, 131:084502.
73. Boerckel J.D., Kolambkar Y.M., Stevens H.Y., Lin A.S., Dupont K.M., Guldberg R.E. Effects of in vivo mechanical loading on large bone defect regeneration. J. Orthop. Res. 2011.
74. Glatt V., Miller M., Matthys R., Evans C. Development of a modulated mechanical environment for enhancing bone healing in a rat segmental defect model. 56th Annual Meeting of the Orthopaedic Research Society 2010, p. 392.
75. McKay W.F., Peckham S.M., Badura J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int. Orthop. 2007, 31:729-734.
76. Schwarz C., Wulsten D., Ellinghaus A., Lienau J., Willie B.M., Duda G.N. Mechanical load modulates the stimulatory effect of BMP2 in a rat nonunion model. Tissue Eng. A 2013, 19:247-254.
77. Kopf J., Petersen A., Duda G.N., Knaus P. BMP2 and mechanical loading cooperatively regulate immediate early signalling events in the BMP pathway. BMC Biol. 2012, 10:37.